- Home
- WATT vs ERNA Comparison
WATT vs ERNA Comparison
Compare WATT & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- ERNA
- Stock Information
- Founded
- WATT 2012
- ERNA 2018
- Country
- WATT United States
- ERNA United States
- Employees
- WATT N/A
- ERNA N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- WATT Technology
- ERNA Health Care
- Exchange
- WATT Nasdaq
- ERNA Nasdaq
- Market Cap
- WATT 9.3M
- ERNA 10.2M
- IPO Year
- WATT 2014
- ERNA N/A
- Fundamental
- Price
- WATT $7.45
- ERNA $1.35
- Analyst Decision
- WATT
- ERNA
- Analyst Count
- WATT 0
- ERNA 0
- Target Price
- WATT N/A
- ERNA N/A
- AVG Volume (30 Days)
- WATT 53.8K
- ERNA 38.4K
- Earning Date
- WATT 07-29-2025
- ERNA 08-13-2025
- Dividend Yield
- WATT N/A
- ERNA N/A
- EPS Growth
- WATT N/A
- ERNA N/A
- EPS
- WATT N/A
- ERNA N/A
- Revenue
- WATT $1,976,000.00
- ERNA $488,000.00
- Revenue This Year
- WATT $1,028.91
- ERNA N/A
- Revenue Next Year
- WATT $117.65
- ERNA N/A
- P/E Ratio
- WATT N/A
- ERNA N/A
- Revenue Growth
- WATT 434.05
- ERNA 201.24
- 52 Week Low
- WATT $3.67
- ERNA $1.33
- 52 Week High
- WATT $81.00
- ERNA $28.65
- Technical
- Relative Strength Index (RSI)
- WATT 39.85
- ERNA 30.15
- Support Level
- WATT $7.04
- ERNA $1.43
- Resistance Level
- WATT $8.41
- ERNA $1.56
- Average True Range (ATR)
- WATT 0.71
- ERNA 0.09
- MACD
- WATT 0.03
- ERNA -0.01
- Stochastic Oscillator
- WATT 70.41
- ERNA 5.41
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.